INBRAIN Neuroelectronics
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Barcelona, Catalonia, Spain, Europe
Region: Catalonia
Country: ES
Continent: Europe
About
Inbrain Neuroelectronics is a neurotechnology company developing breakthrough neuroelectronic therapies to decode and modulate neural networks. The company combines graphene-based, skin-like brain-computer interfaces with an implantable neural processor to provide high-resolution, bidirectional neural interfacing and real-time neural decoding in a closed-loop system. Their end-to-end platform integrates hardware and data analytics to personalize therapy and improve outcomes for patients, with a focus on neurological disorders and conditions such as Parkinson’s disease. Headquartered in Barcelona, Spain, Inbrain emphasizes advancing safe, scalable neural therapies and has received FDA Breakthrough Device designation for its work in Parkinson’s disease.
Inbrain Neuroelectronics develops neuroelectronic therapies that decode and modulate neural networks using graphene-based brain-computer interfaces and implantable neural processors. The company provides a closed-loop platform for real-time neural decoding, targeting patients with neurological disorders such as Parkinson’s disease. Its end-to-end solution integrates hardware and data analytics to
INBRAIN Neuroelectronics S.L.
2020
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Grant
68100000
private
Investors
Founders
Anton Guimera
Carolina Aguilar
Jose Garrido
Kostas Kostarelos
Leadership
Technology Stack
Products
Graphene-based Brain-Computer Interface (BCI) Neural Platform: A neural interface system using graphene technology for high-resolution, bi-directional brain signal decoding and modulation.
INNERVIA Bioelectronics: A subsidiary developing intelligent graphene-based bioelectronic systems for selective vagus nerve modulation targeting chronic diseases.